Anxiety, Depression, PTSD Common With Implantable Cardioverter Defibrillators
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 21, 2023 -- Depression and anxiety are highly prevalent in patients with an implantable cardioverter defibrillator (ICD), according to a review published in the June issue of EP Europace.
Erica S. Ghezzi, from the University of South Australia in Adelaide, and colleagues conducted a systematic literature review to estimate the prevalence of mood disorders and symptom severities at pre- and post-ICD insertions.
Based on 109 articles (39,954 patients), the researchers found that clinically relevant anxiety was reported for 22.58 percent of ICD patients across all timepoints following insertion. Depression was seen in 15.42 percent of ICD patients and posttraumatic stress disorder was seen in 12.43 percent. Rates were similar across indication groups. Patients who experienced shocks had a higher likelihood of clinically relevant anxiety and depression (odds ratios, 3.92 and 1.87 for anxiety and depression, respectively). For anxiety, higher symptoms were seen in women versus men postinsertion (Hedges' g = 0.39). In the first five months postinsertion, depression symptoms decreased (Hedges' g = 0.13), and anxiety symptoms decreased after six months (Hedges' g = 0.07).
"Psychological assessment, monitoring, and therapy should be offered to ICD patients and their partners as part of routine care," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Bidirectional Link ID'd for Change in Depressive Symptoms, Memory Change
THURSDAY, June 13, 2024 -- A linear change in depressive symptoms is associated with accelerated memory change and vice versa in adults aged 50 years or older, according to a...
Exposure to Depressive Symptoms Linked to Worse Cognitive Function
WEDNESDAY, June 12, 2024 -- Exposure to elevated depressive symptoms starting in young adulthood is associated with worse cognitive function over midlife, with the association...
Females Have Higher Genetic Risk for PTSD
WEDNESDAY, June 12, 2024 -- The genetic influences of posttraumatic stress disorder (PTSD) are stronger in females than males, according to a study published online June 4 in The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.